v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Net Cash Provided by (Used in) Operating Activities [Abstract]    
Net earnings $ 83,961 $ 71,155
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 37,958 36,622
Stock compensation expense 9,838 8,809
Deferred income taxes 1,513 (806)
Provision for doubtful accounts 379 105
Unrealized gain on foreign currency transaction and deferred compensation (1,262) (534)
Asset impairment charge 23 0
Loss/(gain) on disposal of assets 259 (996)
Changes in assets and liabilities    
Accounts receivable (14,678) (14,088)
Inventories (30,370) (11,736)
Prepaid expenses and other current assets (690) (3,793)
Accounts payable and accrued expenses 14,358 30,467
Income taxes (5,732) (681)
Other 1,324 1,499
Net cash provided by operating activities 96,881 116,023
Cash flows from investing activities:    
Cash paid for acquisitions, net of cash acquired (365,780) 0
Capital expenditures and intangible assets acquired (35,793) (22,391)
Proceeds from insurance and sale of assets 198 1,272
Investment in affiliates (150) 0
Net cash used in investing activities (401,525) (21,119)
Cash flows from financing activities:    
Proceeds from revolving loan 435,000 5,000
Principal payments on revolving loan (81,000) (60,000)
Principal payments on acquired debt (30,782) 0
Cash paid for financing costs (1,232) 0
Principal payments on finance lease (125) (118)
Proceeds from stock options exercised 2,172 6,351
Dividends paid (20,708) (18,704)
Purchase of common stock (35,245) (18,762)
Net cash provided by (used in) financing activities 268,080 (86,233)
Effect of exchange rate changes on cash (10,186) (3,229)
(Decrease) increase in cash and cash equivalents (46,750) 5,442
Cash and cash equivalents beginning of period 103,239 84,571
Cash and cash equivalents end of period $ 56,489 $ 90,013